Abstract:The aim of this contribution is to develop a universal method to promote the serum-tolerant capability of polycation-based gene delivery system. A “hydroxylation camouflage” strategy was put forward by coating the polycation vectors with hydroxyl-enriched “skin”. Branched polyethyleneimine (PEI) was herein used as the polycation model and modified via the catalyst-free aminolysis reaction with 5-ethyl-5-(hydroxymethyl)-1,3-dioxan-2-oxo (EHDO). PEI-g-EHDO, PEI and alkylated PEI derivative termed as PEI-g-DPA were comparatively explored with respect to the transfection efficiency in the serum-free and serum-conditioned medium. The resultant data indicate that the serum-tolerant capability largely depended on the surface composition and substitution degree. In addition to the reduced surface charge, the introduced function caused by hydroxyl coating is believed to play a crucial role for the improved properties of PEI-g-EHDOs. The EHDO modification can effectively inhibit the adsorption of BSA proteins onto polyplexes surface. And the polyplexes stability was remarkably enhanced in the presence of DNase and heparin after EHDO modification. Note that the transfection activity of PEI-g-EHDO34.5% in the serum-conditioned medium was even higher than that without serum addition. In contrast, serum addition led to appreciable reduction in the transfection efficiency mediated by PEI and PEI-g-DPAs. Specifically, as far as the transfection activity in the presence of serum is concerned, PEI-g-EHDO could be up to 30-fold higher than unmodified PEI25k. PEI-g-EHDO34.5% displayed little to no hemolytic effect and high cell-biocompatibility with nearly no cytotoxicity detected in 293T cells and HeLa cells. Taking into account the high biocompatibility and serum-tolerant transfection activity, PEI-g-EHDO34.5% holds great potential for the use as efficient gene vector. More importantly, it is expected that such “hydroxylation camouflage” strategy may be universally applicable for a majority of existing polycation vectors.

Increase of the pharmacological and pharmacokinetic efficacy of negatively charged polypeptide recombinant hirudin in rats via parenteral route by association with cationic liposomes.

Controlled Delivery of Recombinant Hirudin Based on Thermo-Sensitive Pluronic® F127 Hydrogel for Subcutaneous Administration: in Vitro and in Vivo Characterization

A Strategy to Improve Serum-Tolerant Transfection Activity of Polycation Vectors by Surface Hydroxylation

Investigation on recombinant hirudin via oral route.

Pharmacodynamics and Pharmacokinetics of Recombinant Hirudin Via Four Non-Parenteral Routes

Correction: Evaluation of a Novel Thermosensitive Heparin-Poloxamer Hydrogel for Improving Vascular Anastomosis Quality and Safety in a Rabbit Model.

Nanoscaled polyion complex micelles for targeted delivery of recombinant hirudin to platelets based on cationic copolymer.

A Novel Zwitterionic Copolymer with A Short Poly(Methyl Acrylic Acid) Block for Improving Both Conjugation and Separation Efficiency of A Protein Without Losing Its Bioactivity

Hirudin: Administration Routes and Formulations

Permeation-enhancing Effects of Chitosan Formulations on Recombinant Hirudin-2 by Nasal Delivery in Vitro and in Vivo.

Expression, Purification and Characterization of the Recombinant Hirudin Variant Iii in the Bacillus Subtilis

Improving long circulation and procoagulant platelet targeting by engineering of hirudin prodrug

In situ formed depot of elastin-like polypeptide-hirudin fusion protein for long-acting antithrombotic therapy

Molecular dynamic and pharmacological studies on protein‐engineered hirudin variants of Hirudinaria manillensis and Hirudo medicinalis

Pharmacokinetic study with N-Ile1-Thr2-63-desulfato-r-hirudin in rabbits by means of bioassay

Efficient targeted anticoagulant with active RGD motif.

Engineering a “three-in-one” hirudin prodrug to reduce bleeding risk: A proof-of-concept study

Effects of surface charge of low molecular weight heparin-modified cationic liposomes on drug efficacy and toxicity

A Novel Hirudin Derivative Characterized with Anti-Platelet Aggregations and Thrombin Inhibition.

The Pharmacokinetics and Pharmacodynamics of Recombinant Hirudin-2 Nasal Spray

Pharmacokinetics and Pharmacology of Hirulog-Like Peptide.